Bionano Genomics (BNGO) Set to Announce Quarterly Earnings on Wednesday

Bionano Genomics (NASDAQ:BNGO) is set to issue its quarterly earnings data after the market closes on Wednesday, November 13th.

Bionano Genomics (NASDAQ:BNGO) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($0.24) EPS for the quarter. Bionano Genomics had a negative return on equity of 151.27% and a negative net margin of 557.98%. The business had revenue of $7.77 million for the quarter. On average, analysts expect Bionano Genomics to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Bionano Genomics Trading Up 0.1 %

NASDAQ:BNGO opened at $0.29 on Friday. Bionano Genomics has a one year low of $0.26 and a one year high of $2.27. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.63 and a quick ratio of 1.11. The company’s 50-day simple moving average is $0.39 and its 200 day simple moving average is $0.62. The firm has a market capitalization of $25.35 million, a P/E ratio of -0.06 and a beta of 2.37.

Analyst Upgrades and Downgrades

BNGO has been the topic of several research reports. Scotiabank reissued a “sector perform” rating and set a $1.00 price objective (down previously from $6.00) on shares of Bionano Genomics in a research note on Wednesday, August 28th. BTIG Research downgraded shares of Bionano Genomics from a “buy” rating to a “neutral” rating in a research report on Tuesday, September 10th.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.